188 related articles for article (PubMed ID: 35819691)
1. A Critical Review on Role of Available Synthetic Drugs and Phytochemicals in Insulin Resistance Treatment by Targeting PTP1B.
Rath P; Ranjan A; Chauhan A; Verma NK; Bhargava A; Prasad R; Jindal T
Appl Biochem Biotechnol; 2022 Oct; 194(10):4683-4701. PubMed ID: 35819691
[TBL] [Abstract][Full Text] [Related]
2. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications.
Teimouri M; Hosseini H; ArabSadeghabadi Z; Babaei-Khorzoughi R; Gorgani-Firuzjaee S; Meshkani R
J Physiol Biochem; 2022 May; 78(2):307-322. PubMed ID: 34988903
[TBL] [Abstract][Full Text] [Related]
3. Improved glucose-stimulated insulin secretion by intra-islet inhibition of protein-tyrosine phosphatase 1B expression in rats fed a high-fat diet.
Lu B; Wu H; Gu P; Du H; Shao J; Wang J; Zou D
J Endocrinol Invest; 2012 Jan; 35(1):63-70. PubMed ID: 21646858
[TBL] [Abstract][Full Text] [Related]
4. [CD36 gene deletion reduces muscle insulin sensitivity in mice by up-regulating PTP1B expression].
Chen L; Zeng H; Qin H; Ruan X; Yang P
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):392-398. PubMed ID: 35426803
[TBL] [Abstract][Full Text] [Related]
5. Protein Tyrosine Phosphatase 1B Inhibitors: A Novel Therapeutic Strategy for the Management of type 2 Diabetes Mellitus.
Prabhakar PK; Sivakumar PM
Curr Pharm Des; 2019; 25(23):2526-2539. PubMed ID: 31333090
[TBL] [Abstract][Full Text] [Related]
6. Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study.
Rocha S; Lucas M; Silva VLM; Gomes PMO; Silva AMS; Araújo AN; Aniceto N; Guedes RC; Corvo ML; Fernandes E; Freitas M
Int J Biol Macromol; 2021 Jun; 181():1171-1182. PubMed ID: 33857515
[TBL] [Abstract][Full Text] [Related]
7. Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance.
Xue B; Kim YB; Lee A; Toschi E; Bonner-Weir S; Kahn CR; Neel BG; Kahn BB
J Biol Chem; 2007 Aug; 282(33):23829-40. PubMed ID: 17545163
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents.
Onoda T; Li W; Higai K; Koike K
BMC Complement Altern Med; 2014 Feb; 14():64. PubMed ID: 24555682
[TBL] [Abstract][Full Text] [Related]
9. Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid.
Yang YM; Seo SY; Kim TH; Kim SG
Hepatology; 2012 Dec; 56(6):2209-20. PubMed ID: 22807119
[TBL] [Abstract][Full Text] [Related]
10. PTP1B inhibitors for type 2 diabetes treatment: a patent review (2011 - 2014).
Tamrakar AK; Maurya CK; Rai AK
Expert Opin Ther Pat; 2014 Oct; 24(10):1101-15. PubMed ID: 25120222
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive review on the antidiabetic activity of flavonoids targeting PTP1B and DPP-4: a structure-activity relationship analysis.
Proença C; Ribeiro D; Freitas M; Carvalho F; Fernandes E
Crit Rev Food Sci Nutr; 2022; 62(15):4095-4151. PubMed ID: 33554619
[TBL] [Abstract][Full Text] [Related]
12. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action.
Zabolotny JM; Haj FG; Kim YB; Kim HJ; Shulman GI; Kim JK; Neel BG; Kahn BB
J Biol Chem; 2004 Jun; 279(23):24844-51. PubMed ID: 15031294
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
[No Abstract] [Full Text] [Related]
14. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
Nandi S; Saxena M
Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
[TBL] [Abstract][Full Text] [Related]
15. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
[TBL] [Abstract][Full Text] [Related]
16. Medicinal Plants and Phytochemicals Regulating Insulin Resistance and Glucose Homeostasis in Type 2 Diabetic Patients: A Clinical Review.
Mahdavi A; Bagherniya M; Mirenayat MS; Atkin SL; Sahebkar A
Adv Exp Med Biol; 2021; 1308():161-183. PubMed ID: 33861444
[TBL] [Abstract][Full Text] [Related]
17. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance.
Goldstein BJ
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):265-75. PubMed ID: 12477292
[TBL] [Abstract][Full Text] [Related]
18. [Research progress of several protein tyrosine phosphatases in diabetes].
Chen M; Sun JP; Liu J; Yu X
Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
Koren S; Fantus IG
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
[TBL] [Abstract][Full Text] [Related]
20. Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model.
Yang SC; Hsu CY; Chou WL; Fang JY; Chuang SY
Molecules; 2020 Dec; 25(23):. PubMed ID: 33287318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
